MXPA05013948A - Proceso para la sintesis de d-(17a)-13-etil-17-hidroxi-18 19-dinor-pregn-4-ene-20-ina-3-ona-oxima. - Google Patents

Proceso para la sintesis de d-(17a)-13-etil-17-hidroxi-18 19-dinor-pregn-4-ene-20-ina-3-ona-oxima.

Info

Publication number
MXPA05013948A
MXPA05013948A MXPA05013948A MXPA05013948A MXPA05013948A MX PA05013948 A MXPA05013948 A MX PA05013948A MX PA05013948 A MXPA05013948 A MX PA05013948A MX PA05013948 A MXPA05013948 A MX PA05013948A MX PA05013948 A MXPA05013948 A MX PA05013948A
Authority
MX
Mexico
Prior art keywords
oxime
17alpha
yne
ene
hydroxy
Prior art date
Application number
MXPA05013948A
Other languages
English (en)
Spanish (es)
Inventor
Laszlo Terdy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of MXPA05013948A publication Critical patent/MXPA05013948A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
MXPA05013948A 2003-06-30 2004-04-29 Proceso para la sintesis de d-(17a)-13-etil-17-hidroxi-18 19-dinor-pregn-4-ene-20-ina-3-ona-oxima. MXPA05013948A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301982A HUP0301982A2 (hu) 2003-06-30 2003-06-30 Eljárás nagy tisztaságú d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-oxim előállítására
PCT/HU2004/000031 WO2005000868A1 (en) 2003-06-30 2004-04-29 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17­hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime

Publications (1)

Publication Number Publication Date
MXPA05013948A true MXPA05013948A (es) 2006-03-09

Family

ID=90001694

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013948A MXPA05013948A (es) 2003-06-30 2004-04-29 Proceso para la sintesis de d-(17a)-13-etil-17-hidroxi-18 19-dinor-pregn-4-ene-20-ina-3-ona-oxima.

Country Status (17)

Country Link
EP (1) EP1638988B1 (https=)
JP (1) JP2007516946A (https=)
CN (1) CN100355771C (https=)
AT (1) ATE462712T1 (https=)
AU (1) AU2004251118A1 (https=)
BR (1) BRPI0412186A (https=)
CA (1) CA2528952A1 (https=)
DE (1) DE602004026306D1 (https=)
EA (1) EA008411B1 (https=)
HR (1) HRP20060038A2 (https=)
HU (1) HUP0301982A2 (https=)
MX (1) MXPA05013948A (https=)
NO (1) NO20060455L (https=)
NZ (1) NZ544378A (https=)
RS (1) RS20050897A (https=)
UA (1) UA80059C2 (https=)
WO (1) WO2005000868A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816546B2 (en) 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
ITMI20052464A1 (it) 2005-12-22 2007-06-23 S N I F F Italia S P A Procedimento per la preparazi9one di norelgestromin norelgestromina
CN108827950B (zh) * 2018-05-31 2020-08-21 成都市科隆化学品有限公司 乙酸中微量乙酸酐的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7306609A (https=) * 1972-05-26 1973-11-28
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
CA2222133C (en) * 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen

Also Published As

Publication number Publication date
HUP0301982D0 (en) 2003-09-29
WO2005000868A1 (en) 2005-01-06
HRP20060038A2 (en) 2006-11-30
EA200600119A1 (ru) 2006-06-30
ATE462712T1 (de) 2010-04-15
JP2007516946A (ja) 2007-06-28
NO20060455L (no) 2006-03-29
CN1805970A (zh) 2006-07-19
HUP0301982A2 (hu) 2005-04-28
NZ544378A (en) 2008-02-29
CN100355771C (zh) 2007-12-19
AU2004251118A1 (en) 2005-01-06
CA2528952A1 (en) 2005-01-06
UA80059C2 (en) 2007-08-10
RS20050897A (sr) 2007-08-03
DE602004026306D1 (de) 2010-05-12
EP1638988B1 (en) 2010-03-31
EP1638988A1 (en) 2006-03-29
EA008411B1 (ru) 2007-04-27
BRPI0412186A (pt) 2006-08-22

Similar Documents

Publication Publication Date Title
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
UA84407C2 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
AU2001237347A1 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
WO2003038072A8 (en) Generation and use of new types of dendritic cells
CA2333192A1 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-one
UA66866C2 (uk) Синтез морфолінових похідних
NO20023276L (no) Fremgangsmåter fremstilling av betulinsyre
AU6921300A (en) Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
MXPA05013948A (es) Proceso para la sintesis de d-(17a)-13-etil-17-hidroxi-18 19-dinor-pregn-4-ene-20-ina-3-ona-oxima.
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
HUP0203812A2 (hu) Eljárás ciklusos aminosavak sztereoszelektív előállítására
WO2002085921A3 (de) Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EP1529783A3 (de) Derivative von 9,10-Dihydro-9-oxa-10-phosphaphenanthren-10-oxid
GB9920959D0 (en) Novel process
IL154828A0 (en) 17alpha FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
AU2003226287A1 (en) Conversion of taxane molecules
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
AU4757000A (en) Method of producing methoxyimino acetic amide
NZ544481A (en) norgestrel 3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers
WO2004093852A3 (en) Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
MY139098A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
AU2003221494A1 (en) Process for the synthesis of pergolide

Legal Events

Date Code Title Description
FG Grant or registration